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Arterial grafting is superior to venous grafting in coronary artery bypass graft surgery with respect to graft
patency and long-term patient outcome, but it may be difficult to achieve complete arterial
revascularization.
Recent findings
Use of arterial grafts, especially bilateral internal mammary artery grafts, is not common, whereas there are
clear indications that it may increase survival. Definitions of complete revascularization are varied and
confusing, making study comparisons difficult. Technical challenges in complete revascularization with
arterial grafts can be minimized by surgical techniques. Competitive flow in moderately stenosed coronary
arteries grafted with arterial conduits may result in reduced patency. While internal mammary arteries may
be used in arteries with at least 60% stenosis, radial artery and gastroepiploic grafts are best placed onto
coronaries with severe stenosis. Moderate lesions in the left coronary circulation should be bypassed, but
right coronary artery lesions can be left untouched as there is minimal progression over time. Complete
revascularization may not be necessary or possible in every patient because of technical challenges.
Conclusion
Complete revascularization with arterial grafts presents both technical and physiological challenges.
However, with techniques to maximize length of arterial conduits, knowledge of competitive flow and which
moderate lesions should be addressed, complete revascularization with arterial grafts can be accomplished in
the majority of patients, notwithstanding it may not be possible or even indicated for every patient.
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As stated by a 29-year-old woman after total
arterial coronary artery bypass graft (CABG) surgery
(‘Doctors always question the scar on my wrist and
are astounded to hear that you used an artery in my
heart; it makes only sense’), arterial grafts for CABG
are intuitively the correct conduit. Just the pressure
difference alone between veins (25–30mmHg) and
arteries (mean pressure 70mmHg) should be
evidence enough of arterial superiority. Why then
do only 4% of patients in North America [1] and
10% in Europe [2] receive bilateral internal mam-
mary artery (BIMA) grafting? The reasons are com-
plex and many: non-belief of the evidence to date,
technical and time demands of use of arterial grafts,
fear of deep sternal wound infection [3], lack of
benefit beyond a certain patient age, perceived mis-
match between arterial graft flow and myocardial
demand, and inertia to change. In addition, sur-
geons find it difficult to completely revascularizeiams & Wilkins. Unauthopatients using only arterial grafts because of tech-
nical (limited length of arterial graft available) and
physiologic factors (competitive flow when moder-
ately stenosed coronary arteries are grafted).EVIDENCE FOR IMPROVED SURVIVAL
AND GRAFT PATENCY WITH ARTERIAL
GRAFTING
As a result of advancements in operative techniques
and myocardial protection, operative mortality ofrized reproduction of this article is prohibited.
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KEY POINTS
 Arterial bypasses, especially BIMA grafting,
portend long-lasting graft patency and improved
survival compared with CABG with predominantly
venous grafts. Multiple definitions of complete
revascularization abound and need careful scrutiny to
compare studies.
 Surgical techniques exist to maximize arterial conduit
length to facilitate complete revascularization with the
finite amount of arterial conduit.
 Arterial conduits to moderately stenosed coronary
arteries may suffer from the effects of competitive flow:
guides exist for minimizing this problem.
 The moderately stenosed coronary artery behaves
differently depending whether it is in the left or right
coronary circulation: right-sided lesions do not progress
and hence may be left not bypassed, whereas left-sided
lesions do progress over time and should
be addressed.
 Incomplete revascularization in some patients may be
‘reasonable’ or ‘appropriate’.
Arterial grafting and complete revascularization Kieser et al.CABG has reduced significantly (1% in planned
cases) [4] and is no longer in question, but the
longevity of the procedure is. As stated by Barner
[5], ‘Only continued patency of a graft or stent
provides benefit.’ Long-term venous graft patency
is disappointing and has not changed for 44 years:
Fitzgibbon et al. [6] reported in 1996 a series of 5065
grafts from 1969 to 1994 (25 years’ span) with
venous graft patency of 50% for at least 15 years,
and Tatoulis et al. [7] reported in 2011 3238 venous
grafts from 1986 to 2008 (22 years’ span) with a
patency of 50.7% at 15 years.
Use of the internal mammary artery (IMA)
began 66 years ago as a myocardial implant by
Vineberg and Jewett [8] in 1947. Evidence for
superior long-term survival for arterial grafting
was reported by multiple authors in the past years.
Kelly et al., in a study of 8264 patients (13% BIMA),
found that risk-adjusted survival at 10 years was
71% [hazard ratio 0.8; 95% confidence interval
(CI) 0.67–1.00] for BIMA grafts, 66% for single
IMA grafts (reference group) and 58% (hazard ratio
1.42; 95% CI 1.2–1.7) for no IMA graft. Only the
right IMA (no other arterial grafts) conferred benefit
[9
&
]. In another study with 8622 Mayo clinic
patients (overall 12%BIMA), use ofmultiple arterial
grafts compared with left IMA/vein was a strong
predictor of survival at 10 (83 vs. 70%) and 15 (80 vs.
60%) years in matched groups (P¼0.0025) [10].
Kurlansky et al. [11] have reported the longest
follow-up to date in a propensity-matched analysisCopyright © Lippincott Williams & Wilkins. Unau
0268-4705  2013 Wolters Kluwer Health | Lippincott Williams & Wilkof 4584 patients who underwent CABG through
1972–1994. Survival at 25 years of follow-up was
significantly improved in BIMA graft patients as
opposed to those receiving only one IMA (29 vs.
16%, respectively; P<0.001) [11].
Bilateral internal mammary artery grafting in
diabetic patients has gained little traction because
the risk of deep sternal wound complications is
particularly high in this subgroup of patients. How-
ever, use of two IMA grafts in diabetic patients has
been recently shown to also increase late survival,
similar to non-diabetic individuals. Puskas et al.
[12
&
] reviewed 3527 patients operated between
2002 and 2010, and showed that there were no
increased propensity score-adjusted rates of 30-day
mortality and sternal wound complications between
the use of BIMA and single IMA grafts in diabetic
patients; however, 8-year survival was 87.4% vs. only
60.6% in BIMA and single IMA patients, respectively
(P<0.001). Furthermore, Dorman et al. [13
&
], in a
cohort of 1107 consecutive patients with diabetes,
showed that median survival of 646 single IMA
patients was 9.8 years compared with 13.1 years
of propensity-matched patients with BIMA grafts
(P¼0.001).
Also for diabetic patients with complex disease
in the SYNergy between Percutaneous Coronary
intervention with TAXus and Cardiac Surgery
(SYNTAX) trial, CABG is preferred over percutane-
ous coronary intervention (PCI) because of fewer
major adverse cardiac or cerebrovascular events and
less repeat revascularization, in keeping with find-
ings from the Freedom trial [14
&
,15].
Radial artery grafts, easier to harvest and use
than the right IMA (RIMA), have some attrition
beyond the first postoperative year, but remain
stable thereafter up to 20 years: at 1.0, 5.4, 8.3
and 13.1 years, respectively, radial artery graft
patency is 86.2, 81.9, 81.4 and 81.6% [16]. Because
of the susceptibility of radial grafts to the effects of
competitive flow (see below), radial grafts should
only be constructed in areas of severe stenosis. As
stated by Alfieri et al. [17] in their paper entitled
‘Drug-eluting stents or drug-eluting conduits for
multivessel disease’, mammary arteries are the very
best conduits. Tatoulis et al. [7], in a series of 5766
patients with BIMA, reported a 15-year patency of
91.1% for the left IMA, 79% for the RIMA and 50.7%
for saphenous vein; 10-year patency for radial artery
grafts was 78%. It is important to note that the
patency of the right and left IMA is identical when
used to the same vessels [7]. Yet, there are still those
who remain to be convinced . . . The Arterial Revas-
cularisation Trial (ART) trial randomizing 3102
patients to either single IMA or BIMA will be the
deciding vote [18].thorized reproduction of this article is prohibited.
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CCoronary artery surgeryDEFINITIONS OF COMPLETE
REVASCULARIZATION
Incomplete revascularization (ICR) varies from 9 to
39% from study to study [19]. One of the difficulties
interpreting the literature on this topic is the many
and varied definitions of complete revascularization
(Table 1) [20–27]. The ‘traditional’ definition
defines complete revascularization as placement
of at least one bypass in all diseased arterial systems
and is basically a ‘territorial’ definition. ‘Functional’
complete revascularization most often refers to the
bypassing of all diseased primary coronary seg-
ments, irrespective of size and territory. However,
the term ‘functional’ has also been used to indicate
bypasses into all territories except to those infarct
areas without viable myocardium [22]. This has led
to completely opposite definitions in some papers,
in which traditional is called functional [28]. The
amount of ‘disease’ (50% [20] or 70% stenosis [21])
varies among studies as well.
The definitions ‘conditional’ or ‘unconditional’
reflect revascularizing vessels of a certain size
[>1.5mm for CABG and PCI in the the Bypass
Angioplasty Revascularization Investigation trial
and >2.75mm for PCI in the Arterial Revasculari-
zation Therapy Study (ARTS) trial] or location (main
or branch) [22]. The definition ‘numeric’ refers to
whether the number of distal anastomoses is eitheropyright © Lippincott Williams & Wilkins. Unautho
Table 1. Definitions of incomplete vs. complete revasculari
Principal definitions Description
Traditional ‘Territorial’ all territories
70%) [21]
Functional ‘Territorial’ without requi
Functional Also called ‘anatomic’, a
(SYNTAX trial is an ex
Numeric Number of stenotic vesse
‘LAD definition’ 2 distal sites to LAD þ
(Number of distal anastomoses to the
LAD or other coronary arteries)
2 distal sites to LAD
2 distal sites to an arte
<2 distal sites to all arte
ICOR (Index of Completeness of
Revascularization)
Number of bypasses per
[25]
Also, number of bypasse
Weighted scoring (continuous variable) Scoring of stenoses in di
a continuous variable,
completeness of revasc
Anatomic Irrespective of viable my
Functional Post-treatment score base
[22]
Conditional Conditions include speci
of above definitions [2
LAD, left anterior descending; PCI, percutaneous coronary intervention.
648 www.co-cardiology.comless than, equal to or greater than the number of
diseased coronary segments [24]. One definition
may be labelled the ‘left anterior descending
(LAD) artery definition’: patients are grouped by
whether they have at least two bypasses to both
LAD and non-LAD system, at least two bypasses to
the LAD, at least two bypasses to non-LAD system or
whether no arterial system had multiple bypasses
[24]. For the definition ‘Index of Completeness of
Revascularization (ICOR)’, complete revasculari-
zation is a ratio of the number performed bypasses
divided by the number of preoperatively planned
bypasses and should be at least 1 [25]. This defi-
nition – because of the necessity of forethought –
cannot be retrospectively applied to observational
studies. However, to circumvent this, the definition
has been extrapolated to be: the total number
of distal anastomoses performed divided by the
number of diseased coronary vessels defined on
preoperative angiography [26,27]. Finally, complete
revascularization can be measured by weighting
stenoses in different vessels (extent of disease is a
continuous variable) and may be ‘anatomic’ (irre-
spective of viable myocardium) or ‘functional’
(using the Jeopardy score to calculate the myo-
cardium at risk after revascularization) [22]. Because
of the different techniques by which PCI and
CABG achieve complete revascularization, it isrized reproduction of this article is prohibited.
zation
diseased receive at least one graft/PCI (stenosis 50% [20] or
rement for non-viable myocardium to be perfused [22]
ll primary coronary segments irrespective of size or territory
ample of this definition) [23]
ls¼ number of distals [24]
another artery
ry other than LAD
ries [24]
formed/number of bypasses preoperatively planned (should be >1)
s performed/number of stenotic arteries [26,27]
fferent vessels at different locations with weighting, disease extent is
treatment is another variable; post treatment score determines
ularization [22]
ocardium [22]
d on amount of viable myocardium still at risk by Jeopardy score
fied vessel diameter or location (main or branch), can apply to any
2]
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Arterial grafting and complete revascularization Kieser et al.questionable whether one definition for both PCI
and CABG is possible or even advisable. Hopefully,
one day, we will reach the utopian goal of no longer
needing comparison of PCI and CABG because the
role for each will be defined; for example, patients
with diabetes [14
&
,15], patients with a SYNTAX score
above and below 33 and so on [29]. This multiplicity
of definitions needs addressing, without which
comparison from study to study is difficult and
may not be meaningful. Forethought and decision
beforehand of vessels potentially treatable by both
the cardiologist and cardiac surgeon of the Heart
Team (as used in the SYNTAX trial) [14
&
], and then
comparingwithwhat was done,may be the best way
to decide completeness of revascularization.
The residual SYNTAX score is a recently pro-
posed definition to grade the degree of complete-
ness of revascularization, adding more detail to
previous dichotomous definitions. It is promising
as a predictor ofmortality during follow-up after PCI
[30
&
,31,32
&
], but has not yet been validated in a
CABG cohort. It will be interesting to see how
it performs, particularly since the original core
SYNTAX score lacks prognostic accuracy [33].TECHNICAL CHALLENGES IN ARTERIAL
GRAFTING FOR CORONARY ARTERY
BYPASS GRAFT SURGERY
When using venous grafts, one can always ‘go and
get more vein’, whereas with arterial grafts there is
only so much conduit available. A large heart may
require ‘creative arterial grafting’ in which various
segments of arterial conduit are attached to each
other to form a composite graft and reach their
target. Technical tricks include the following:(1)Co
0268Skeletonization of the IMAs [34] adds consider-
able length and also facilitates sequential graft-
ing because the correct ‘lie’ of the conduit can be
judged accurately when the whole circumfer-
ence of the IMA is seen (when performing the
side-to-side anastomosis of a sequential graft).(2) The length of an arterial graft is maximized if
placed ‘as the crow flies’, that is, as direct a route
as possible to the target. For example, for either
the left or right IMA to reach the LAD, one can
bring the conduit through a hole in the pericar-
dium (or make a slit) instead of going ‘up and
over’ the pericardial reflection. First pleural tis-
sue is swept away to avoid entering the pleural
cavity, then cautery is used to make a small hole
in the pericardium, enough to admit two fin-
gers. In order for the RIMA to reach the right
coronary artery (RCA) system, pericardial holes
are made in different locations depending onpyright © Lippincott Williams & Wilkins. Unautho
-4705  2013 Wolters Kluwer Health | Lippincott Williams & Wilkinsthe location of the target: for a RIMA graft to the
main RCA or postero-lateral branch of the RCA,
the pericardial hole is made adjacent to the
‘superior vena cava’, and to graft the posterior
descending artery (PDA), the hole is made near
the ‘inferior vena cava’ (personal communi-
cation from Dr Pascal Berdat of Berne, Switzer-
land, July 2003). This route to the PDA is extra-
pericardial (may facilitate re-operation if
needed); the IMA seems longer with this route,
usually reaches the PDA and allows the ‘turn-
point’ of the IMA to be tethered by the pericar-
dial edge, ensuring a correct lie of the distal
segment of the RIMA. This allows no twisting
at the heel.In the authors’ experience of almost 10 years of
1047 patients with 98% arterial grafts, by using this
technique, the RIMA–PDA was used as a free graft
13% of the time (26/194 RIMA to PDA). For this
same group of 1047 patients, a total of 748 RIMA
conduits included 309 (41%) RIMA conduits to RCA
system and 439 (59%) to left coronary artery (LCA)
system. For the RIMA to the circumflex system, the
most direct route is usually through a hole in the
pericardium just above the superior vena cava and
through the transverse sinus to reach the marginal
branches. A skeletonized IMA beating against an
occluding clip or bulldog wrapped in a vasodilator
solution usually lengthens enough to reach most
branches of the circumflex system in situ. In the
authors’ experience, for this same group of 1047
patients, the RIMA–LCA system was used as a free
graft only 9% of the time (40/439 RIMA-to-LCA
system). Although it may be twice as difficult to
use the RIMA as the left internal mammary artery
(LIMA), patients get close to twice as many grafts at
15 years (90 vs. 50% patent grafts). The radial artery
is almost as easy to use as a saphenous vein and in
factmay be ‘the new saphenous vein’. Onemust just
be cognizant of the native coronary stenosis and use
the radial when appropriate (in coronary arteries
with 90% stenosis or higher, see below).COMPETITIVE FLOW AND ARTERIAL
GRAFTING
Venous grafts have virtually no resistance (the pres-
sure at the distal anastomosis is nearly equal to the
aortic pressure) and hence are less susceptible to the
adverse effects of competitive flow [35
&&
]. Arterial
grafts ‘auto-regulate in response to demand’ [36];
flow in an arterial graft will rise and fall as is needed.
Arterial grafts have one Achilles heel – competitive
flow if grafted into coronary arteries with moderate
stenosis. Themost severe form of ‘non-requirement’rized reproduction of this article is prohibited.
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CCoronary artery surgeryresults in a ‘string sign’ – on angiography, the graft
looks like an atretic thread attached to the coronary
artery. Conversely, arterial grafts increase their
diameter over time [35
&&
] and, in particular, left
IMAs have been known to revascularize the whole
of the LCA circulation in cases of isolated/predom-
inant left main stenosis (Fig. 1). IMAs are the arterial
conduit least affected by competitive flow; generally
there is no critical level of stenosis belowwhich graft
flow is compromised [5]. Sabik et al. [37] studied
2121 IMAs from 1972 to 1999, and found that,
although IMA patency diminished as the degree
of coronary stenosis decreased, at no particular
degree of stenosis was there a sharp decline in
patency. Glineur et al. [38] showed that composite
‘Y’ IMA grafting to both the RCA and LCA systems
had a negative prognostic influence on graft func-
tion, with loss of the graft to the RCA system.
Possibly the different diastolic filling of the right
(50%) and left coronary arteries (66%) could explain
this: the RCA segment fails because two disparate
pressure systems are grafted with one inflow.
For the radial artery graft, Barner [5] was the first
to identify the relation of native coronary stenosis
and radial artery patency; he found that patencywas
worse in moderate stenosis (70%) compared with
critical stenosis (90%). Shah’s review showed
radial artery graft patency to be significantly
reduced from 90 to 60% when grafts were placed
to fewer than 70% stenotic arteries [39]. In the
Radial Artery Patency Study, Desai et al. [40] foundopyright © Lippincott Williams & Wilkins. Unautho
FIGURE 1. LIMA graft supplying all of LCA system in a
patient with predominantly left main stenosis. LCA, left
coronary artery; LIMA, left internal mammary artery.
650 www.co-cardiology.comthat radial grafts to coronary arteries with stenosis
of at least 90% as compared with those with
stenosis of 70–89% were associated with a lower
rate of occlusion (5.9 vs. 11.8%). Composite grafts
using the radial and IMA to the left circulation
therefore need to take this into account as well.
The right gastroepiploic artery, similar to the
radial artery, is recommended to be used only
on severely stenotic coronary arteries [41]. Some
of these guidelines are difficult to implement for
arterial grafting in that the conduit that ‘reaches’
may not be the most appropriate conduit for that
particular coronary [e.g. a long graft (radial) is
needed for two branches on the RCA system, but
the stenoses are only 70%].WHAT ABOUT MODERATE STENOSIS?
If arterial grafts are better, but are subject to the
vagaries of competitive flow, should moderate
stenosis be left alone? Hayward et al. [42
&&
] answered
this when he studied 386 bypass grafts to moder-
ately (40–69%) stenosed coronary arteries from the
Radial Artery Patency and Clinical Outcomes trial.
During a mean of 6.2 years follow-up in non-
bypassed coronary arteries, moderate lesion pro-
gression differed according to location: only one
in seven moderate lesions in the RCA showed sig-
nificant progression (frommoderate to severe) com-
pared with one in two for left-sided coronary vessels.
Conversely, however, when a moderately diseased
coronary artery in the RCA systemwas bypassed, the
native lesions progressed to severe 40% of the time
vs. 14% of the time if not bypassed. Competitive
flow from grafts seemed to cause greater disease
progression in right-sided vessels than in left-sided
vessels; as well, right-sided grafts tended to have
inferior patency (73.3% at 7 years vs. 83.2% at
8 years; P¼0.051). He concluded that it is advisable
to bypass moderate lesions of the left coronary
system because of the likelihood of progression,
but leave right-sided moderate lesions alone, given
the low risk of progression if left undisturbed.
The use of fractional flow reserve has been
shown to assist in deciding which lesions are best
treated by angioplasty [43]; possibly the same may
prove to be useful in deciding which moderate
lesions should be grafted.With this new knowledge,
that which constitutes ‘completeness of revasculari-
zation’ may need to be rethought.IS COMPLETE REVASCULARIZATION
ALWAYS NECESSARY?
Reduced survival after CABG is multifactorial and
cannot be attributed solely to incompletenessrized reproduction of this article is prohibited.
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Table 2. Comparison of studies with differing amounts of arterial grafting
Grafts Author, year
Number of
patients
Length of
follow-up
(years)
Survival
(ICR) (%)
Survival
(CR) (%) Comparison
Venous grafts only McNeer et al., 1974 392 2 75% 83 NS
IMAþ vein Mohammadi et al.,
2012
476 8 49 54 P¼0.40
Kim et al., 2011 514 5 90 87 P¼0.26
Sarno, 2010 567 5 91 93 P¼0.48
Aziz, 2009 580 8 34 44 P<0.01
Lattouf et al., 2008 12812 10 58b– –68b P<0.001;
HR¼0.85 (95%
CI 0.77–0.93)
Kozower, 2005 500 8 25 39 P<0.008
Arterial (more
than usual)
Farooq et al., SYNTAX,
2013a
1541 (22.7% BIMA) 4 88 92 P¼0.039
Vieira et al., MASS II,
2012
198 (36% IMAþradial) 10 88b 91b NS
Girerd et al., 2012 6539 (4.4–10.9% BIMA) 6 82 88 P<0.001
Head et al., SYNTAX,
2012c
870 (27.6% BIMA) 3 93 94 P¼0.60
Rastan et al., 2009 8806 (22–32% TAG) 5 54 61 P¼0.77
Kleisli et al., 2005 1034 5 53 82 P<0.001
CABG, coronary artery bypass graft; CR, complete revascularization; HR, hazard ratio; ICR, incomplete revascularization; IMA, internal mammary artery; MASS
II, Second Medicine, Angioplasty, or Surgery Study; NS, not significant.
aIn comparison with Head et al., this group also includes patients both in the trial and in the CABG registry.
bEstimate from survival graphs in paper.
cIncludes only trial patients.
Arterial grafting and complete revascularization Kieser et al.of revascularization [4]. Also, not all studies have
shown that incomplete revascularization in CABG
results in impaired survival [19,21,44,46–48,51]
Table 2 shows 13 studies [19,21,27,28,32
&
,44–51]
comparing completeness of revascularization at
follow-up times ranging from 2 to 10 years relating
to the amount of arterial grafting.’ In the SYNTAX
trial with 27.6% BIMA [23,51,52], in the CABG
group, no difference in outcomes was seen between
incomplete and complete revascularization groups.
Incomplete revascularization was identified as an
independent predictor of Major Adverse Cardiac
and Cerebrovascular Event (MACCE) in PCI (hazard
ratio 1.55, 95% CI 1.15–2.08, P¼0.004), but not
CABG patients. Rastan et al. spoke about ‘reasonable
ICR’, noting that most often the territory not
bypassed involves either the RCA or circumflex
territory, which may or may not portend worse
outcomes, especially if, as in their study, arterial
grafting was more frequent [19]. Taggart [53
&&
] dis-
cussed the ‘appropriateness’ of ICR, noting that
inability to completely revascularize often is a
marker for more severe and diffuse disease. It is
not ‘appropriate’ to place a bypass graft into an
infarct area, or into a small target vessel, risking
graft failure and possible infarct.Copyright © Lippincott Williams & Wilkins. Unau
0268-4705  2013 Wolters Kluwer Health | Lippincott Williams & WilkCONCLUSION
Arterial grafting is thought to be superior for graft
longevity and patient survival, and we anxiously
await the results of the ART trial to confirm this
[18]. The definitions of ICR are as varied as is the
incidence of ICR in the literature. Although techni-
cally challenging, it is possible to achieve complete
revascularization with arterial grafts, especially if
one skeletonizes the IMAs and as much as possible
follows guidelines correlating the conduit type to
level of stenosis in order to avoid competitive flow.
Moderate lesions on the RCA system should prob-
ably be left alone as they do not progress (one in
seven), whereas those in the left coronary system
should be bypassed because of their progression over
time (one in two). Finally, ‘the enemy of good is
perfect’, and it may not be necessary to achieve
completeness of revascularization each and every
time.Acknowledgements
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